ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      Current Value of Holding

      $244M

      Shares

      1.35M

      % of Portfolio

      1.27%

      Average Buy Price

      $78.8

      Avg closing price
      Price range

      46 Chris Davis Quest Diagnostics Trades

      Chris Davis's position in Quest Diagnostics is currently worth $244M. That's 1.27% of their equity portfolio (22nd largest holding). The investor owns 1.20% of the outstanding Quest Diagnostics stock. The first Quest Diagnostics trade was made in Q1 2014. Since then Chris Davis bought shares sixteen more times and sold shares on 29 occasions. The stake costed the investor $107M, netting the investor a gain of 129% so far.

      Avg closing price
      Price range
      Sold 43.3% shares (-1.03M shares) Q2 2025
      Avg closing price $173.59
      Price range $159.80 - $182.07
      Sold 0.4% shares (-8.96k shares) Q1 2025
      Avg closing price $163.98
      Price range $150.33 - $176.95
      Sold 0.1% shares (-1.84k shares) Q4 2024
      Avg closing price $155.59
      Price range $146.90 - $163.89
      Increased shares by 0.3% (+8.28k shares) Q3 2024
      Avg closing price $149.33
      Price range $136.64 - $156.97
      Increased shares by 0.4% (+9.67k shares) Q2 2024
      Avg closing price $136.94
      Price range $125.91 - $144.34
      Sold 10.7% shares (-285k shares) Q1 2024
      Avg closing price $129.75
      Price range $123.78 - $142.11
      Increased shares by 59.9% (+999k shares) Q4 2023
      Avg closing price $131.47
      Price range $120.62 - $141.12
      Increased shares by 10.2% (+154k shares) Q3 2023
      Avg closing price $133.24
      Price range $121.86 - $144.92
      Sold 0.3% shares (-4.86k shares) Q2 2023
      Avg closing price $137.86
      Price range $130.56 - $146.84
      Sold 17.3% shares (-317k shares) Q1 2023
      Avg closing price $143.07
      Price range $131.53 - $155.77
      Sold 1.9% shares (-35.3k shares) Q4 2022
      Avg closing price $143.70
      Price range $123.31 - $157.28
      Sold 1.0% shares (-18.7k shares) Q3 2022
      Avg closing price $131.69
      Price range $121.77 - $141.10
      Sold 2.9% shares (-57.2k shares) Q2 2022
      Avg closing price $136.26
      Price range $127.07 - $145.39
      Sold 3.0% shares (-59.6k shares) Q1 2022
      Avg closing price $139.38
      Price range $129.09 - $164.35
      Sold 26.8% shares (-736k shares) Q4 2021
      Avg closing price $152.16
      Price range $140.36 - $173.01
      Sold 2.6% shares (-72.7k shares) Q3 2021
      Avg closing price $146.32
      Price range $132.95 - $158.00
      Increased shares by 1.4% (+37.5k shares) Q2 2021
      Avg closing price $130.93
      Price range $126.66 - $141.48
      Sold 5.1% shares (-150k shares) Q1 2021
      Avg closing price $123.22
      Price range $114.63 - $133.34
      Sold 21.8% shares (-818k shares) Q4 2020
      Avg closing price $121.91
      Price range $112.70 - $128.05
      Sold 3.3% shares (-128k shares) Q3 2020
      Avg closing price $118.15
      Price range $107.05 - $130.01

      News about Quest Diagnostics, Inc. and Chris Davis

      Quest Diagnostics to acquire Canada's LifeLabs for about $985 million including debt

      Quest Diagnostics to acquire Canada's LifeLabs for about $985 million including debt

      Quest Diagnostics Inc. DGX, -0.33% said Wednesday it has entered a definitive agreement with pension fund OMERS to acquire LifeLabs, a Canadian provider of c...

      marketwatch.com marketwatch.com, about 1 year ago
      Quest Diagnostics to Speak at the 2024 Leerink Partners Healthcare Crossroads Conference

      Quest Diagnostics to Speak at the 2024 Leerink Partners Healthcare Crossroads Conference

      SECAUCUS, N.J. , May 7, 2024 /PRNewswire/ --?Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Jim Davi...

      prnewswire.com prnewswire.com, over 1 year ago
      Quest Diagnostics to Speak at the 42nd Annual J.P. Morgan Healthcare Conference

      Quest Diagnostics to Speak at the 42nd Annual J.P. Morgan Healthcare Conference

      SECAUCUS, N.J., Dec. 21, 2023 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation''s leading provider of diagnostic information services, ...

      PR Newswire PR Newswire, over 1 year ago
      Quest Diagnostics, Inc. (DGX) Q2 2023 Earnings Call Transcript

      Quest Diagnostics, Inc. (DGX) Q2 2023 Earnings Call Transcript

      Quest Diagnostics, Inc. (NYSE:NYSE:DGX) Q2 2023 Earnings Conference Call July 26, 2023 8:30 AM ETCompany ParticipantsShawn Bevec - VP, IRJames Davis - Chairm...

      Seeking Alpha Seeking Alpha, about 2 years ago

      Embed chart

      Easily embed the chart on your blog or website ¨C it will always update automatically!

      HoMEÔçÒÒŮѸÀ×